111 related articles for article (PubMed ID: 10672785)
1. A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorption.
Plusquellec Y; Efthymiopoulos C; Duthil P; Houin G
Med Eng Phys; 1999 Oct; 21(8):525-32. PubMed ID: 10672785
[TBL] [Abstract][Full Text] [Related]
2. Applications and simulations of a discontinuous oral absorption pharmacokinetic model.
Witcher JW; Boudinot FD
Pharm Res; 1996 Nov; 13(11):1720-4. PubMed ID: 8956341
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two compartmental models for describing ranitidine's plasmatic profiles.
Schaiquevich P; Niselman A; Rubio M
Pharmacol Res; 2002 May; 45(5):399-405. PubMed ID: 12123628
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic compartmental model with n sites of absorption along the gastrointestinal tract.
Plusquellec Y; Houin G
Arzneimittelforschung; 1994 May; 44(5):679-82. PubMed ID: 8024648
[TBL] [Abstract][Full Text] [Related]
5. Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles.
Suttle AB; Pollack GM; Brouwer KL
Pharm Res; 1992 Mar; 9(3):350-6. PubMed ID: 1614968
[TBL] [Abstract][Full Text] [Related]
6. Effect of silymarin on the oral bioavailability of ranitidine in healthy human volunteers.
Rao BN; Srinivas M; Kumar YS; Rao YM
Drug Metabol Drug Interact; 2007; 22(2-3):175-85. PubMed ID: 17708067
[TBL] [Abstract][Full Text] [Related]
7. A modified two-portion absorption model to describe double-peak absorption profiles of ranitidine.
Yin OQ; Tomlinson B; Chow AH; Chow MS
Clin Pharmacokinet; 2003; 42(2):179-92. PubMed ID: 12537516
[TBL] [Abstract][Full Text] [Related]
8. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
Lee HT; Lee YJ; Chung SJ; Shim CK
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
[TBL] [Abstract][Full Text] [Related]
9. Plasma pharmacokinetics of ranitidine HCl in foals.
Holland PS; Brumbaugh GW; Ruoff WW; Brown SA
J Vet Pharmacol Ther; 1997 Dec; 20(6):447-52. PubMed ID: 9430768
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and bioavailability of ranitidine in humans.
Miller R
J Pharm Sci; 1984 Oct; 73(10):1376-9. PubMed ID: 6094785
[TBL] [Abstract][Full Text] [Related]
11. Use of the InteliSite capsule to study ranitidine absorption from various sites within the human intestinal tract.
Pithavala YK; Heizer WD; Parr AF; O'Connor-Semmes RL; Brouwer KL
Pharm Res; 1998 Dec; 15(12):1869-75. PubMed ID: 9892471
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal absorption of a new reversible proton pump inhibitor, YJA-20379-8, and its pharmacokinetics after oral administration in acetic acid-induced gastric ulcer in rats.
Chung SY; Han KS; Kim HJ; Kim J; Chang MS; Lee MG
J Pharm Pharmacol; 1999 Sep; 51(9):1025-30. PubMed ID: 10528985
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of a formulation containing a diclofenac-ranitidine combination.
Carrasco-Portugal Mdel C; Aguilar-Cota ME; Pérez-Urizar J; Cabrera O; Herrera JE; Flores-Murrieta FJ
Proc West Pharmacol Soc; 2002; 45():8-10. PubMed ID: 12434510
[No Abstract] [Full Text] [Related]
14. Bioavailability of ranitidine in healthy Mexican volunteers: effect of food.
Juárez-Olguín H; Flores J; Pérez G; Hernández G; Flores C; Guillé A; Camacho A; Toledo A; Carrasco M; Lares I
Proc West Pharmacol Soc; 2002; 45():156-8. PubMed ID: 12434565
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic analysis of an oral sustained-release diltiazem preparation using multifraction absorption models.
Murata K; Noda K
Pharm Res; 1993 May; 10(5):757-62. PubMed ID: 8321842
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine.
Radwanski E; Nomeir A; Cutler D; Affrime M; Lin CC
Am J Ther; 1998 Mar; 5(2):67-72. PubMed ID: 10099040
[TBL] [Abstract][Full Text] [Related]
17. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
Stampfuss J; Kubitza D; Becka M; Mueck W
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
Stass H; Böttcher MF; Ochmann K
Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
[TBL] [Abstract][Full Text] [Related]
19. Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine.
Basit AW; Podczeck F; Newton JM; Waddington WA; Ell PJ; Lacey LF
Pharm Res; 2002 Sep; 19(9):1368-74. PubMed ID: 12403075
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
